Investor

Nerveda

Last cheque observed Jan 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

Series ABiotechnologyHealth CareHealth Diagnostics

Cheques on record
0%of best year0cheques in 12 months, 1 on record
Since the last cheque4309days00hrs00min00sec
Median round$6.0MRounds led0 of 1
Pitch Nerveda

Nerveda highlights

  1. 01

    1 rounds on record

  2. 02

    Mostly Series A: 100% of its rounds

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
BiotechnologyHealth CareHealth Diagnostics
Cold pitches
Not stated

The record

Every round we can evidence, newest first1 appearances

  1. 2015

    1 round

  2. Jan
    RetroSense TherapeuticsSeries A · US$6.0MWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Quick answers about Nerveda

What does Nerveda invest in?

Nerveda invests most often at Series A (100% of the rounds on record), in sectors such as Biotechnology, Health Care and Health Diagnostics.

How active is Nerveda?

1 investments on record, 0 of them in the last 12 months. The most recent was in Jan 2015.

How big are Nerveda's cheques?

The median round it joins is $6.0M.

Is Nerveda investing now?

No investments in the last 12 months; the latest was in Jan 2015.

What kind of investor is Nerveda?

Nerveda is a VC firm.

When was Nerveda founded?

Nerveda was founded in 2007.

Where does this information on Nerveda come from?

From public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it